Diabetes Frail Ltd   Report issue

Foundation Phase 3
Founded: Luton United Kingdom (2014)

Organization Overview

First Clinical Trial
2016
NCT02484209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Diabetes Frail Ltd

Active Ingredients

Drugs in Phase 3 Trials (2)

glimepiride (amaryl) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2